Total genome polymorphism and low frequency of intra-genomic variation in the uspA1 and uspA2 genes of Moraxella catarrhalis in otitis prone and non-prone children up to 2 years of age : Consequences for vaccine design?
Intra-genomic variation in the uspA1 and uspA2 genes of Moraxella catarrhalis was studied using pulsed field gel electrophoresis (PFGE) and polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis. From a set of 91 M. catarrhalis isolates, 19 pairs of PFGE identical iso...
Gespeichert in:
Veröffentlicht in: | Vaccine 2003-03, Vol.21 (11), p.1118-1124 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Intra-genomic variation in the
uspA1 and
uspA2 genes of
Moraxella catarrhalis was studied using pulsed field gel electrophoresis (PFGE) and polymerase chain reaction–restriction fragment length polymorphism (PCR-RFLP) analysis. From a set of 91
M. catarrhalis isolates, 19 pairs of PFGE identical isolates were found. Five pairs originated from otitis non-prone children, 11 pairs from otitis prone children and for 3 pairs, one of the pair originated from an otitis prone and the other from an otitis non-prone child. No particular
M. catarrhalis isolate was associated with either the otitis prone or non-prone children. One of these 19 pairs of isolates was found to exhibit both
uspA1 and
uspA2 intra-genomic variation, whilst another pair exhibited
uspA2 intra-genomic variation only. Sequence data obtained from these variants showed that PCR-RFLP pattern differences reflected actual changes in predicted amino acid composition and that minor amino acid changes in a 23 base pair “NINNIY” repeat region (a conserved UspA1 and UspA2 binding site for the neutralising antibody mAb17C7) occurred. Variation in the
uspA2 5’ non-coding “AGAT” repeat region was also observed. These results may have implications for future
M. catarrhalis vaccines comprising UspA1 or UspA2 components. |
---|---|
ISSN: | 0264-410X 1873-2518 |
DOI: | 10.1016/S0264-410X(02)00522-4 |